249 related articles for article (PubMed ID: 33416845)
1. Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review.
Joher N; Gosset C; Guerrot D; Pillebout E; Hummel A; Boffa JJ; Faguer S; Rabant M; Higgins S; Moktefi A; Delmas Y; Karras A; Lapidus N; Amiot A; Audard V; El Karoui K
Nephrol Dial Transplant; 2022 Feb; 37(3):531-539. PubMed ID: 33416845
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Histopathological Profile of Immunoglobulin A Nephropathy Patients in Central Part of India: A Single-Center Study.
Balwani MR; Pasari A; Bhawane A; Tolani P
Saudi J Kidney Dis Transpl; 2022; 33(2):307-312. PubMed ID: 37417183
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
6. Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions.
Neves PDMM; Pinheiro RBB; Dias CB; Yu L; Testagrossa LA; Cavalcante LB; Malheiros DMAC; Jorge LB; Woronik V
Kidney Blood Press Res; 2020; 45(3):431-441. PubMed ID: 32299081
[TBL] [Abstract][Full Text] [Related]
7. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
9. IgA Nephropathy in Children: A Multicenter Study in Poland.
Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
[TBL] [Abstract][Full Text] [Related]
10. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
Zeng CH; Le W; Ni Z; Zhang M; Miao L; Luo P; Wang R; Lv Z; Chen J; Tian J; Chen N; Pan X; Fu P; Hu Z; Wang L; Fan Q; Zheng H; Zhang D; Wang Y; Huo Y; Lin H; Chen S; Sun S; Wang Y; Liu Z; Liu D; Ma L; Pan T; Zhang A; Jiang X; Xing C; Sun B; Zhou Q; Tang W; Liu F; Liu Y; Liang S; Xu F; Huang Q; Shen H; Wang J; Shyr Y; Phillips S; Troyanov S; Fogo A; Liu ZH
Am J Kidney Dis; 2012 Nov; 60(5):812-20. PubMed ID: 22819700
[TBL] [Abstract][Full Text] [Related]
11. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).
Schimpf JI; Klein T; Fitzner C; Eitner F; Porubsky S; Hilgers RD; Floege J; Groene HJ; Rauen T
BMC Nephrol; 2018 Nov; 19(1):328. PubMed ID: 30453889
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
[TBL] [Abstract][Full Text] [Related]
13. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
[TBL] [Abstract][Full Text] [Related]
14. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C;
Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
17. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
19. Pediatric IgA Nephropathy in Europe.
Coppo R
Kidney Dis (Basel); 2019 Jun; 5(3):182-188. PubMed ID: 31259180
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
